Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma PatientAndrea Boutros, Paola Queirolo, Giuseppe Murdaca et al.|Frontiers in Immunology|2020Cited by 15